Mineralys Therapeutics【MLYS】銘柄情報

Mineralys Therapeutics Inc (MLYS) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

27.69

( 2.98% )

買値

24.99

売値

27.91

出来高

700,796

26.76 日の範囲 27.77

12.59 52 週間の範囲 47.65

時価総額

2.441B

前日終値

26.89

始値

27.20

時刻

27.15

最終取引時間

財務取引量

US$ 19,094,055

VWAP

27.2462

平均取引量 (3 か月)

US$ 1,578,638

発行済株式数

88,158,479

配当利回り

PER

-13.3

1 株当たり利益 (EPS)

-2.02

歳入

純利益

-151.78M

Mineralys Therapeutics, Inc., a biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States. It is developing lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of cardiorena... Mineralys Therapeutics, Inc., a biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States. It is developing lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of cardiorenal conditions affected by dysregulated aldosterone, such as hypertension, chronic kidney disease, and obstructive sleep apnea. The company was formerly known as Catalys SC1, Inc. and changed its name to Mineralys Therapeutics, Inc. in May 2020. Mineralys Therapeutics, Inc. was incorporated in 2019 and is headquartered in Radnor, Pennsylvania. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

mineralystx.com

本社

Radnor, United States

設立

2026

Mineralys Therapeutics Inc is listed in the Healthcare sector of the ナスダック市場 with ticker MLYS. The last closing price for Mineralys Therapeutics was US$26.89. Over the last year, Mineralys Therapeutics shares have traded in a share price range of US$ 12.59 to US$ 47.65.

Mineralys Therapeutics currently has 88,158,479 shares in issue. The market capitalisation of Mineralys Therapeutics is US$2.44 billion. Mineralys Therapeutics has a price to earnings ratio (PE ratio) of -13.30.

全体の流れ

ブルリッシュ

ネットプレミアム

25k

Calls / Puts

50.00%

買い / 売り

0.00%

OTM / ITM

0.00%

Sweeps比率

0.00%

Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)

– Lorundrostat was associated with significant reductions in heart failure risk biomarkers in a proteomic...

Mineralys Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

RADNOR, Pa., June 08, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a...

Mineralys Therapeutics to Present Late-Breaking Data on Lorundrostat at The Endocrine Society Annual Meeting (ENDO 2026)

RADNOR, Pa., June 08, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a...

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Mineralys Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock

RADNOR, Pa., June 03, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a...

Form 8-K - Current report

Mineralys Therapeutics Announces Repurchase of Royalty Obligations in Tanabe License Agreement and Concurrent Financing

– Repurchase of lorundrostat royalty obligation in Tanabe license agreement for $200 million upfront and up to...

Mineralys Therapeutics Presents New Data from the Phase 3 Launch-HTN Trial of Lorundrostat in Participants with Hypertension and Chronic Kidney Disease at European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)

– Post hoc analysis from pivotal Launch-HTN trial shows statistically significant and clinically meaningful...

Mineralys Therapeutics to Participate in the Jefferies Global Healthcare Conference

RADNOR, Pa., May 27, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	2.15	8.41816758027	25.54	27.93	25.44	2229287	26.7602819	CS
4	2.54	10.0994035785	25.15	27.93	22.3	2125152	24.99141783	CS
12	0.31	1.13221329438	27.38	32.14	22.3	1581352	26.83676058	CS
26	-8.55	-23.5927152318	36.24	37.7	22.3	1410815	27.88896951	CS
52	13.98	101.969365427	13.71	47.65	12.59	1451098	30.87419017	CS
156	10.69	62.8823529412	17	47.65	5.85	724996	25.04037878	CS
260	6.59	31.2322274882	21.1	47.65	5.85	666313	24.72604713	CS